Home > Items where Subject is "B Substances > New (novel) psychoactive substances > Other novel substances > Xylazine, detomidine, medetomidine"

up arrow imageUp a level
Export as
Group by: Item Type | No Grouping
Number of items at this level: 22.


Edinoff, Amber N and Sall, Saveen and Upshaw, William C and Spillers, Noah J and Vincik, LeighAnn Y and De Witt, Adalyn S and Murnane, Kevin S and Kaye, Adam M and Kaye, Alan D (2024) Xylazine: a drug adulterant of clinical concern. Current Pain and Headache Reports , 28 , pp. 417-426.

Cano, Manuel and Daniulaityte, Raminta and Marsiglia, Flavio (2024) Xylazine in overdose deaths and forensic drug reports in US States, 2019-2022. JAMA Network Open , 7 .

Copeland, Caroline S and Rice, Kathleen and Rock, Kirsten L and Hudson, Simon and Streete, Peter and Lawson, Alexander J and Couchman, Lewis and Holland, Adam and Morley, Stephen (2024) Broad evidence of xylazine in the UK illicit drug market beyond heroin supplies: Triangulating from toxicology, drug-testing and law enforcement. Addiction , 119 , (7) , pp. 1301-1309.

Dahan, Albert and Franko, Thomas S and Carroll, James W and Craig, David S and Crow, Callie and Galinkin, Jeffrey L and Garrity, Justin C and Peterson, Joanne and Rausch, David B (2024) Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids. Frontiers in Public Health , 12 .

Sue, Kimberly L and Hawk, Kathryn (2024) Editorial. Clinical considerations for the management of xylazine overdoses and xylazine-related wounds. Addiction , 119 , (4) , pp. 606-608.

Nahar, Limon K and Andrews, Rebecca and Paterson, Sue (2023) Rapid response: Evolving use of recreational drugs in UK – Nitazenes and Xylazine. BMJ , 383 , p. 2280.

Zagorski, Claire M and Hosey, Rebecca A and Moraff, Christopher and Ferguson, Aaron and Figgatt, Mary and Aronowitz, Shoshana and Stahl, Natalie E and Hill, Lucas G and McElligott, Zoe and Dasgupta, Nabarun (2023) Reducing the harms of xylazine: clinical approaches, research deficits, and public health context. Harm Reduction Journal , 20 .

Rock, Kirsten L and Lawson, Alexander J and Duffy, Joanne and Mellor, Alice and Treble, Ric and Copeland, Caroline S (2023) The first drug-related death associated with xylazine use in the UK and Europe. Journal of Forensic and Legal Medicine , 97 .


Public Health Scotland. (2024) Scotland. Public health alert: Xylazine – newly detected drug. Edinburgh: Public Health Scotland.

Advisory Council on the Misuse of Drugs. (2024) A review of the evidence on the use and harms of xylazine, medetomidine and detomidine. London: Advisory Council on the Misuse of Drugs.

Krotulski, Alex J and Manini, Alex F and Schwarz, Evan and Walton, Sara E and Fogarty, Melissa F and Logan, Barry K (2023) Medetomidine – NPS Discovery new drug monograph. United States: Center for Forensic Science Research & Education.

WEDINOS. (2023) PHILTRE annual report April 2022 - March 2023. Cardiff: WEDINOS.

International Narcotics Control Board. (2023) Report of the International Narcotics Control Board for 2022. Vienna: United Nations.

Harm Reduction International. (2022) The global state of harm reduction 2022. London: Harm Reduction International.

Krotulski, Alex J and Shinefeld, Jennifer and DeBord, Joshua and Logan, Barry K (2022) Fentanyl purity, potency, & synthesis: real-time testing of opioid drug products in the United States. USA: Center for Forensic Science Research and Education.

Centre on Drug Policy Evaluation. (2022) What’s contaminating Toronto’s drug supply? insights from samples checked by Toronto’s drug checking service January 1 - December 31, 2021. Toronto: Centre on Drug Policy Evaluation.

Canadian Centre on Substance Use and Addiction. (2022) CCENDU drug alert: Xylazine. Ottawa: Canadian Centre on Substance Use and Addiction.


European Monitoring Centre for Drugs and Drug Addiction. (2023) Most recent data from the European Syringe Collection and Analysis Project Enterprise (ESCAPE): data explorer, analysis and key findings. URL: https://www.emcdda.europa.eu/publications/data-fac...


Addiction Technology Transfer Center Network. (2023) Understanding Xylazine: an emerging concern. Addiction Technology Transfer Center Network.


Society for the Study of Addiction. Calder, Robert (2024) Addiction audio. Season 2, 2024. London: Society for the Study of Addiction.


Center for Forensic Science Research & Education. US public alerts: Medetomidine rapidly proliferating across USA — implicated in recreational opioid drug supply & causing overdose outbreaks. (20 May 2024)

[RTE radio] , Byrne, Claire ‘Zombie’ drug xylazine found in UK vapes – could it be here? (10 Apr 2024)

This list was generated on Sat Jun 15 04:32:10 2024 IST.